These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 33582201)

  • 1. Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476.
    Steinhauer K; Meister TL; Todt D; Krawczyk A; Paßvogel L; Becker B; Paulmann D; Bischoff B; Pfaender S; Brill FHH; Steinmann E
    J Hosp Infect; 2021 May; 111():180-183. PubMed ID: 33582201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective
    Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
    J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial.
    Elzein R; Abdel-Sater F; Fakhreddine S; Hanna PA; Feghali R; Hamad H; Ayoub F
    J Evid Based Dent Pract; 2021 Sep; 21(3):101584. PubMed ID: 34479668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of various gargle formulations and salt water against SARS-CoV-2.
    Tiong V; Hassandarvish P; Bakar SA; Mohamed NA; Wan Sulaiman WS; Baharom N; Abdul Samad FN; Isahak I
    Sci Rep; 2021 Oct; 11(1):20502. PubMed ID: 34654867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a Mouthwash Containing CHX and CPC in SARS-CoV-2-Positive Patients: A Randomized Controlled Clinical Trial.
    Bonn EL; Rohrhofer A; Audebert FX; Lang H; Auer DL; Scholz KJ; Schuster P; Wenzel JJ; Hiller KA; Buchalla W; Gottsauner JM; Vielsmeier V; Schmidt B; Cieplik F
    J Dent Res; 2023 Jun; 102(6):608-615. PubMed ID: 36942423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preprocedural mouthwashes for infection control in dentistry-an update.
    Weber J; Bonn EL; Auer DL; Kirschneck C; Buchalla W; Scholz KJ; Cieplik F
    Clin Oral Investig; 2023 Jun; 27(Suppl 1):33-44. PubMed ID: 37079156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of mouthwashes against COVID-19 in dentistry.
    Vergara-Buenaventura A; Castro-Ruiz C
    Br J Oral Maxillofac Surg; 2020 Oct; 58(8):924-927. PubMed ID: 32859459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European tiered approach for virucidal efficacy testing - rationale for rapidly selecting disinfectants against emerging and re-emerging viral diseases.
    Eggers M; Schwebke I; Suchomel M; Fotheringham V; Gebel J; Meyer B; Morace G; Roedger HJ; Roques C; Visa P; Steinhauer K
    Euro Surveill; 2021 Jan; 26(3):. PubMed ID: 33478622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is chlorhexidine mouthwash effective in lowering COVID-19 viral load? A systematic review.
    Rahman GS; Alshetan AAN; Alotaibi SSO; Alaskar BMI; Baseer MA
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):366-377. PubMed ID: 36647885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of mouthwash against SARS-CoV-2 infection: A review of scientific and clinical evidence.
    Chen MH; Chang PC
    J Formos Med Assoc; 2022 May; 121(5):879-885. PubMed ID: 34666923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of octenidine- and chlorhexidine-based wash-mitts against Candida albicans and Candida auris - a comparative study.
    Gugsch F; Tan CK; Oh DY; Paßvogel L; Steinhauer K
    J Hosp Infect; 2024 Jan; 143():91-96. PubMed ID: 37949371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effect of mouthwashes against SARS-COV-2: A systematic review.
    Mezarina Mendoza JPI; Trelles Ubillús BP; Salcedo Bolívar GT; Castañeda Palacios RDP; Herrera Lopez PSG; Padilla Rodríguez DA; Uchima Koecklin KH
    Saudi Dent J; 2022 Mar; 34(3):167-193. PubMed ID: 35125835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2.
    Steinhauer K; Meister TL; Todt D; Krawczyk A; Paßvogel L; Becker B; Paulmann D; Bischoff B; Eggers M; Pfaender S; Brill FHH; Steinmann E
    J Hosp Infect; 2021 Jun; 112():27-30. PubMed ID: 33771601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of oral antiseptics for SARS-CoV-2 infection.
    Palop Larrea V; Hernández Rodríguez MÁ
    Med Clin (Barc); 2020 Nov; 155(9):416-417. PubMed ID: 32778429
    [No Abstract]   [Full Text] [Related]  

  • 15. Could certain mouthwashes reduce transmissibility of COVID-19?
    Elmahgoub F; Coll Y
    Evid Based Dent; 2021 Jan; 22(2):82-83. PubMed ID: 34172918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent evidence sustains the use of chlorhexidine-based mouthwash for dental patients during the coronavirus disease 2019 epidemic.
    Barenghi L; Barenghi A; Garagiola U; Giannì AB; Spadari F
    Am J Orthod Dentofacial Orthop; 2022 Mar; 161(3):322-323. PubMed ID: 35184842
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro virucidal activity of mouthwashes on SARS-CoV-2.
    Buonavoglia A; Lanave G; Marchi S; Lorusso P; Montomoli E; Martella V; Camero M; Prati C; Trombetta CM
    Oral Dis; 2022 Nov; 28 Suppl 2():2509-2515. PubMed ID: 35398970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do hydrogen peroxide mouthwashes have a virucidal effect? A systematic review.
    Ortega KL; Rech BO; El Haje GLC; Gallo CB; Pérez-Sayáns M; Braz-Silva PH
    J Hosp Infect; 2020 Dec; 106(4):657-662. PubMed ID: 33058941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2.
    Ferrer MD; Barrueco ÁS; Martinez-Beneyto Y; Mateos-Moreno MV; Ausina-Márquez V; García-Vázquez E; Puche-Torres M; Giner MJF; González AC; Coello JMS; Rueda IA; Aubá JMV; Español CC; Velasco AL; Abad DS; García-Esteban S; Artacho A; López-Labrador X; Mira A
    Sci Rep; 2021 Dec; 11(1):24392. PubMed ID: 34937855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.
    Khan MM; Parab SR; Paranjape M
    Am J Otolaryngol; 2020; 41(5):102618. PubMed ID: 32574894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.